Neonatal HBV: Difference between revisions

From IDWiki
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Background==
* If mother has hepatitis B, or her status is unknown, then consider post-exposure prophylaxis with [[hepatitis B immune globulin]] and [[hepatitis B vaccine]] given within 12 hours of life

** Vaccine prevents about 90% of infections, with HBIG adding a bit more
===Epidemiology===
** HBIG can be given up to 7 days of life but is most effective when given earlier

* Also see article on [[neonatal HIV]]
*Transmitted perinatally during delivery (rarely transmitted in utero)
**Highest risk is with acute infection during the third trimester
*Transmission from HBsAg-positive mothers is 30% if HBeAg-negative and 85% if HBeAg-positive

==Clinical Manifestations==

*80-90% of infected infants will develop chronic infection
*Mostly asymptomatic

==Prevention==

*Mother should take [[tenofovir]] starting at 28-32 weeks gestation if viral load is greater than 200,000 IU/mL, until 3 months postpartum
**See also [[Hepatitis B in pregnancy#Management|hepatitis B in pregnancy]]
*If mother has active [[hepatitis B]] (that is, HBsAg is positive) or if her status is unknown, then consider post-exposure prophylaxis with [[hepatitis B immune globulin]] and [[hepatitis B vaccine]] given within 12 hours of life
**Vaccine prevents about 90% of infections, with HBIG adding a bit more
**HBIG can be given up to 7 days of life but is most effective when given earlier
**Vaccine and HBIG should be given in separate limbs
**Overall, decreases transmission from 30-85% down to 1-2%
*No need for Cesarean section to prevent transmission
*Monitoring
**Completion of routine vaccination schedule
***If the birth weight is less than 2000 g, the birth dose should not count towards their vaccine series
**Postvaccination HBsAg serology is recommended for children born to HBsAg-positive mothers
***Usually at age 9 to 12 months
***HBsAg negative with HBsAb ≥10 mIU/mL: no further management
***HBsAg negative with HBsAb <10 mIU/mL: give another dose of vaccine and repeat testing in 1 to 2 months
****If still <10 mIU/mL, then give two additional doses to complete a full second series and repeat testing in 1 to 2 months
***HBsAg positive: refer for management
**Even if not infected, maternal HBcAb may persist in the baby up to 24 months of age
*Recommend breastfeeding if the infant received appropriate prophylaxis
*Remember to screen other family members for [[Hepatitis B virus|hepatitis B]]
*Also see article on [[neonatal HIV]]

==Further Reading==

*Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. ''MMWR Recomm Rep''. 2018;67(RR-1):1-31. doi: [https://doi.org/10.15585/mmwr.rr6701a1 10.15585/mmwr.rr6701a1]


[[Category:Infectious diseases]]
[[Category:Infectious diseases]]

Latest revision as of 10:36, 6 December 2020

Background

Epidemiology

  • Transmitted perinatally during delivery (rarely transmitted in utero)
    • Highest risk is with acute infection during the third trimester
  • Transmission from HBsAg-positive mothers is 30% if HBeAg-negative and 85% if HBeAg-positive

Clinical Manifestations

  • 80-90% of infected infants will develop chronic infection
  • Mostly asymptomatic

Prevention

  • Mother should take tenofovir starting at 28-32 weeks gestation if viral load is greater than 200,000 IU/mL, until 3 months postpartum
  • If mother has active hepatitis B (that is, HBsAg is positive) or if her status is unknown, then consider post-exposure prophylaxis with hepatitis B immune globulin and hepatitis B vaccine given within 12 hours of life
    • Vaccine prevents about 90% of infections, with HBIG adding a bit more
    • HBIG can be given up to 7 days of life but is most effective when given earlier
    • Vaccine and HBIG should be given in separate limbs
    • Overall, decreases transmission from 30-85% down to 1-2%
  • No need for Cesarean section to prevent transmission
  • Monitoring
    • Completion of routine vaccination schedule
      • If the birth weight is less than 2000 g, the birth dose should not count towards their vaccine series
    • Postvaccination HBsAg serology is recommended for children born to HBsAg-positive mothers
      • Usually at age 9 to 12 months
      • HBsAg negative with HBsAb ≥10 mIU/mL: no further management
      • HBsAg negative with HBsAb <10 mIU/mL: give another dose of vaccine and repeat testing in 1 to 2 months
        • If still <10 mIU/mL, then give two additional doses to complete a full second series and repeat testing in 1 to 2 months
      • HBsAg positive: refer for management
    • Even if not infected, maternal HBcAb may persist in the baby up to 24 months of age
  • Recommend breastfeeding if the infant received appropriate prophylaxis
  • Remember to screen other family members for hepatitis B
  • Also see article on neonatal HIV

Further Reading

  • Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67(RR-1):1-31. doi: 10.15585/mmwr.rr6701a1